Most cited papers from Vivus (United States)

Vivus (United States)

What are the most cited papers from Vivus (United States)?

The most cited paper from Vivus (United States) is "Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial" (Kishore M. Gadde, David Blair Allison, Donna H. Ryan et al., 2011), with 1,062 citations. Next come "Controlled‐Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)" (725) and "Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study" (715).

Published TypeFieldAccessCitations

Showing 50 of 61 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial Kishore M. Gadde, David Blair Allison, Donna H. Ryan et al. · The Lancet	Apr 2011	1,062
2	Controlled‐Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP) David Blair Allison, Kishore M. Gadde, William Timothy Garvey et al. · Obesity Open access	3 Nov 2011	725
3	Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study William Timothy Garvey, Donna H. Ryan, Michelle Look et al. · American Journal of Clinical Nutrition Open access	8 Dec 2011	715
4	Treatment of Men with Erectile Dysfunction with Transurethral Alprostadil Harin Padma-Nathan, Wayne J.G. Hellstrom, Fran E. Kaiser et al. · New England Journal of Medicine Open access	2 Jan 1997	584
5	Evaluation of phentermine and topiramate versus phentermine/topiramate extended‐release in obese adults Louis J. Aronne, Thomas A. Wadden, Craig A. Peterson et al. · Obesity	17 Oct 2013	269
6	Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release William Timothy Garvey, Donna H. Ryan, Robert R. Henry et al. · Diabetes Care Open access	9 Oct 2013	215
7	A Randomized, Double-Blind, Placebo-Controlled Study of an Oral, Extended-Release Formulation of Phentermine/Topiramate for the Treatment of Obstructive Sleep Apnea in Obese Adults David H. Winslow, Charles H. Bowden, Karen P. DiDonato et al. · SLEEP Open access	31 Oct 2012	164
8	Weight-Loss Therapy in Type 2 Diabetes: Effects of Phentermine and Topiramate Extended Release William Timothy Garvey, Donna H. Ryan, Nancy J.V. Bohannon et al. · Diabetes Care Open access	24 Sep 2014	149
9	Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT 2s Catherine E. Thomas, Elizabeth A. Mauer, Alpana P. Shukla et al. · Obesity Open access	29 Aug 2016	123
10	Cardiovascular effects of phentermine and topiramate Jens Jordan, Arne Vernon Astrup, Stefan Engeli et al. · Journal of Hypertension Open access	12 Mar 2014	121
11	A Phase 3, Placebo Controlled Study of the Safety and Efficacy of Avanafil for the Treatment of Erectile Dysfunction After Nerve Sparing Radical Prostatectomy John P. Mulhall, Arthur L. “Bud” Burnett, Run Wang et al. · The Journal of Urology	4 Dec 2012	106
12	A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Avanafil in Subjects with Erectile Dysfunction Irwin Goldstein, Andrew McCullough, LeRoy A. Jones et al. · The Journal of Sexual Medicine	17 Jan 2012	106
13	Efficacy and safety of transurethral alprostadil therapy in men with erectile dysfunction Williams, Williams, Abbou et al. · British Journal of Urology	Jun 1998	94
14	Topiramate use in pregnancy and the birth prevalence of oral clefts Daniel I. Mines, Patricia S. Tennis, Suellen M. Curkendall et al. · Pharmacoepidemiology and Drug Safety	Apr 2014	85
15	Avanafil for the Treatment of Erectile Dysfunction: A Multicenter, Randomized, Double-Blind Study in Men With Diabetes Mellitus Irwin Goldstein, LeRoy A. Jones, Laurence H Belkoff et al. · Mayo Clinic Proceedings Open access	Aug 2012	84
16	A double-blind, placebo-controlled evaluation of the erectile response to transurethral alprostadil Wayne J.G. Hellstrom, Alan Hugh Bennett, Neil Gesundheit et al. · Urology	Dec 1996	80
17	Selectivity of Avanafil, a PDE5 Inhibitor for the Treatment of Erectile Dysfunction: Implications for Clinical Safety and Improved Tolerability Run Wang, Arthur L. “Bud” Burnett, Warren H. Heller et al. · The Journal of Sexual Medicine	3 Jul 2012	80
18	Avanafil, a Potent and Highly Selective Phosphodiesterase-5 Inhibitor for Erectile Dysfunction Jun Kotera, Hideki Mochida, Hirotaka Inoue et al. · The Journal of Urology	15 Jun 2012	64
19	Low-Dose Estradiol Spray to Treat Vasomotor Symptoms John E. Buster, William D. Koltun, Maria Luz G. Pascual et al. · Obstetrics and Gynecology	Jun 2008	57
20	Improving the characteristics of a transducer using multiple piezoelectric layers John A. Hossack, B. A. Auld · IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control	Mar 1993	55
21	An open-label, long-term evaluation of the safety, efficacy and tolerability of avanafil in male patients with mild to severe erectile dysfunction Laurence H Belkoff, A. McCullough, Irwin Goldstein et al. · International Journal of Clinical Practice Open access	24 Mar 2013	52
22	A randomized, double‐blind, placebo‐controlled, pharmacokinetic and pharmacodynamic study of a fixed‐dose combination of phentermine/topiramate in adolescents with obesity Daniel S. Hsia, Nathalie H. Gosselin, Jenna M. Williams et al. · Diabetes Obesity and Metabolism	7 Nov 2019	47
23	Cardiovascular Safety During and After Use of Phentermine and Topiramate Mary E. Ritchey, Abenah Harding, Shannon M. Hunter et al. · The Journal of Clinical Endocrinology & Metabolism Open access	21 Sep 2018	42
24	Soft tissue temperature rise caused by scanned, diagnostic ultrasound Michael G. Curley · IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control	1993	39
25	Utilization of Topiramate During Pregnancy and Risk of Birth Defects Mark W. Green, John D. Seeger, Craig A. Peterson et al. · Headache The Journal of Head and Face Pain	22 Jun 2012	37
26	Efficacy of Avanafil 15 Minutes after Dosing in Men with Erectile Dysfunction: A Randomized, Double-Blind, Placebo Controlled Study Wayne J.G. Hellstrom, Jed C. Kaminetsky, Laurence H Belkoff et al. · The Journal of Urology	12 Jan 2015	35
27	Cost-Effectiveness Analysis of Qsymia for Weight Loss Eric Andrew Finkelstein, Eliza Kruger, Sunil Karnawat · PharmacoEconomics Open access	2 Jul 2014	35
28	Dual Hormonal Replacement Therapy with Insulin and Recombinant Human Insulin-Like Growth Factor (IGF)-I in Insulin-Dependent Diabetes Mellitus: Effects on the Growth Hormone/IGF/IGF-Binding Protein System* Kathryn M. Thrailkill, Teresa Quattrin, Lester Baker et al. · The Journal of Clinical Endocrinology & Metabolism Open access	Apr 1997	34
29	Changes in Cardiovascular Risk Associated With Phentermine and Topiramate Extended-Release in Participants With Comorbidities and a Body Mass Index ≥27 kg/m2 Michael H. Davidson, Serena Tonstad, Suzanne Oparil et al. · The American Journal of Cardiology Open access	29 Jan 2013	31
30	A phase II , single‐blind, randomized, crossover evaluation of the safety and efficacy of avanafil using visual sexual stimulation in patients with mild to moderate erectile dysfunction Wayne J.G. Hellstrom, Matthew T. Freier, Ege Can Şerefoğlu et al. · British Journal of Urology	12 Jul 2012	30
31	Hemodynamic effect of avanafil and glyceryl trinitrate coadministration Dennis Swearingen, Ajay X. Nehra, Susie Morelos et al. · Drugs in Context Open access	2013	28
32	Topiramate use during pregnancy and major congenital malformations in multiple populations Patricia S. Tennis, K. Arnold Chan, Suellen M. Curkendall et al. · Birth Defects Research Part A Clinical and Molecular Teratology	16 Mar 2015	28
33	Health-related quality of life in two randomized controlled trials of phentermine/topiramate for obesity: What mediates improvement? Ronette L. Kolotkin, Kishore M. Gadde, Craig A. Peterson et al. · Quality of Life Research	7 Oct 2015	24
34	Topical alprostadil (PGE1) for the treatment of female sexual arousal disorder: In-clinic evaluation of safety and efficacy Julia R. Heiman, MARC C. GITTELMAN, Raymond A. Costabile et al. · Journal of Psychosomatic Obstetrics & Gynecology	2006	19
35	The effects of skin-to-skin contact, application site washing, and sunscreen use on the pharmacokinetics of estradiol from a metered-dose transdermal spray Robert J. Schumacher, David J. Gattermeir, Craig A. Peterson et al. · Menopause The Journal of The North American Menopause Society	2009	18
36	HEMODYNAMIC EFFECTS OF TRANSURETHRAL ALPROSTADIL MEASURED BY COLOR DUPLEX ULTRASONOGRAPHY IN MEN WITH ERECTILE DYSFUNCTION Peter Yuk‐Him Tam, T Keller, Roberta Poppiti et al. · The Journal of Urology	Oct 1998	17
37	Sensing of Real Environment by Stereo Omnidirectional System (SOS) Kazuhiko Yamamoto, Hideki Tanahashi, Yoshinori Niwa et al. · IEEJ Transactions on Electronics Information and Systems Open access	2001	15
38	Steady‐State Pharmacokinetics Following Application of a Novel Transdermal Estradiol Spray in Healthy Postmenopausal Women Terri L. Morton, David J. Gattermeir, Craig A. Petersen et al. · The Journal of Clinical Pharmacology	24 Jul 2009	15
39	Does obesity associate with mortality among hispanic persons? Results from the national health interview survey Tapan S. Mehta, Raymond O. McCubrey, Nicholas M. Pajewski et al. · Obesity Open access	17 Apr 2013	15
40	Avanafil, a Highly Selective Phosphodiesterase Type 5 Inhibitor for Erectile Dysfunction, Shows Good Safety Profiles for Retinal Function and Hemodynamics in Anesthetized Dogs Hideki Mochida, Koji Yano, Hirotaka Inoue et al. · The Journal of Urology	12 Jan 2013	14
41	Application of selective CVD tungsten for low contact resistance via filling to aluminum multilayer interconnection Sung Min Rang, Robert Hsiu-Ping Chow, Ronald H. Wilson et al. · Journal of Electronic Materials	May 1988	10
42	Registered report: androgen receptor splice variants determine taxane sensitivity in prostate cancer Xiaochuan Shan, Gwenn A. Danet-Desnoyers, Juan José Fung et al. · PeerJ Open access	15 Sep 2015	10
43	Feline penile erection induced by transurethral administration of sodium nitroprusside Trinity Jude Bivalacqua, Hunter C. Champion, Run Wang et al. · Urological Research	20 Dec 1999	9
44	Incidence of fibrosing colonopathy with pancreatic enzyme replacement therapy in patients with cystic fibrosis Stephanie E. Chiuve, Daniel Fife, Gerhard J. Leitz et al. · Journal of Cystic Fibrosis Open access	23 Oct 2023	7
45	A framework for physician assistant intervention for overweight and obesity Lawrence M Herman, John G. McGinnity, Michael C. Doll et al. · JAAPA	25 Jun 2015	6
46	Issues and answers in CAD tool interoperability Mike Murray, Uwe B. Meding, Bill Berg et al. Conference paper	1996	4
47	Effect of Weight Loss (WL) on Concomitant Medication Costs in Obese/Overweight individuals with Metabolic Syndrome (METS) receiving Phentermine/Topiramate extended-release (PHEN/TPM ER) Scott I. Kahan, S. Karnawat · Value in Health Open access	May 2015	3
48	Steady-state pharmacokinetics following application of a novel transdermal estradiol spray in healthy postmenopausal women T. Morton, Craig A. Peterson, Wesley W. Day et al. · Fertility and Sterility Open access	Sep 2008	3
49	Addition of Phentermine‐Topiramate to a Digitally Enhanced Lifestyle Intervention: A Double‐Blind Randomized Clinical Trial Alejandro Campos, Wissam Ghusn, Lizeth Cifuentes et al. · Obesity Open access	21 Jan 2026	1
50	Pluralizm metod stosowanych w nauce o liturgii Ks. Helmut J. Sobeczko · Studia Nauk Teologicznych PAN Open access	10 Apr 2018	1

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.